Publicidad
Imágenes de Interés 14 de diciembre de 2018

PET/CT con F18-colina para la caracterización de lesión ósea lítico-blástica única en un paciente con cáncer de próstata

Referenciar Imprimir Descargar PDF

Referencias

  1. Poulsen MH, Petersen H, Høilund-Carlsen PF, et al. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT. BJU Int 2014;114:818-23.
  2. Zattoni F, Agostini E, Cattaneo F, et al. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer. Clin Imaging 2017;43:110-6.
  3. Evangelista L, Cimitan M, Zattoni F, et al. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- to-high-risk prostate cancer: A retrospective analysis. Scand J Urol 2015;49:345-53.
  4. Zengerling F, Schrader AJ, Schrader M, Jentzmik F. Diagnostic relevance of choline-PET / CT in patients with prostate cancer. Aktuelle Urol 2012;43:49-54.